MEI Pharma Inc (MEIP) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

MEI Pharma Inc

NASDAQ | MEIP

1.97

USD

+0.0158 (+0.81%)

AT CLOSE (AS OF Apr 17, 2025)

$13M

MARKET CAP

P/E Ratio

-5.73

EPS

$4.1

52 Week High

$1.5

52 Week Low

LIFE SCIENCES

Sector

MEIP Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

MEIP Technicals

Tags:

MEIP Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field	Value (USD)
Gross Profit	$65M
Total Revenue	$65M
Cost Of Revenue	$383K
Costof Goods And Services Sold	$383K
Operating Income	$15M
Selling General And Administrative	$23M
Research And Development	$17M
Operating Expenses	$51M
Investment Income Net	-
Net Interest Income	$3.3M
Interest Income	$3.3M
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$383K
Income Before Tax	$18M
Income Tax Expense	$7.6M
Interest And Debt Expense	-
Net Income From Continuing Operations	$18M
Comprehensive Income Net Of Tax	-
Ebit	$26M
Ebitda	$26M
Net Income	$18M

Revenue & Profitability

Earnings Performance

MEIP Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Jun 30, 2024)

Field	Value (USD)
Total Assets	$41M
Total Current Assets	$41M
Cash And Cash Equivalents At Carrying Value	$3.7M
Cash And Short Term Investments	$3.7M
Inventory	-
Current Net Receivables	-
Total Non Current Assets	$606K
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	$35M
Other Current Assets	$2.4M
Other Non Current Assets	-
Total Liabilities	$8.4M
Total Current Liabilities	$8.4M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	-
Total Non Current Liabilities	$0
Capital Lease Obligations	$0
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	-
Other Current Liabilities	$5.2M
Other Non Current Liabilities	-
Total Shareholder Equity	$33M
Treasury Stock	-
Retained Earnings	-$388M
Common Stock	-
Common Stock Shares Outstanding	$6.7M

yearly Cash Flow (As of Jun 30, 2024)

Field	Value (USD)
Operating Cashflow	-$50M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$383K
Capital Expenditures	$7K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$12M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$12M
Dividend Payout Common Stock	$12M
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$18M

yearly Income Statement (As of Jun 30, 2024)

Field	Value (USD)
Gross Profit	$65M
Total Revenue	$65M
Cost Of Revenue	$383K
Costof Goods And Services Sold	$383K
Operating Income	$15M
Selling General And Administrative	$23M
Research And Development	$17M
Operating Expenses	$51M
Investment Income Net	-
Net Interest Income	$3.3M
Interest Income	$3.3M
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$383K
Income Before Tax	$18M
Income Tax Expense	$7.6M
Interest And Debt Expense	-
Net Income From Continuing Operations	$18M
Comprehensive Income Net Of Tax	-
Ebit	$26M
Ebitda	$26M
Net Income	$18M

Dividends

Field	Value
Ex Dividend Date	2023-11-16
Declaration Date	2023-11-06
Record Date	2023-11-17
Payment Date	2023-12-06
Amount	1.75

MEIP News

MEIP Profile

MEI Pharma Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

MEI Pharma, Inc., an advanced stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.00	9.68%	-	409,386,220
STSS	$0.03	20.75%	$522.68K	391,799,240
NVDA	$101.49	-2.87%	$2.48T	292,517,465
HTZ	$8.24	44.31%	$2.54B	266,908,117
FMTO	$0.02	-35.81%	$2.41M	198,396,141

Symbol	Price	Change %	Market Cap	Volume
LLY	$839.96	14.30%	$754.27B	10,853,385
PG	$170.63	2.55%	$400.10B	7,227,061
JNJ	$157.47	2.31%	$379.48B	10,981,067
ABBV	$172.99	0.76%	$306.02B	8,998,056
NVO	$58.08	-7.63%	$282.79B	32,220,629

Symbol	Price	Change %	Market Cap	Volume
MSGM	$2.75	145.54%	$8.75M	36,058,545
SXTC	$2.16	118.42%	$29.73M	51,508,885
ADGM	$1.78	92.81%	$54.65M	114,733,769
PNBK	$3.28	73.55%	$13.04M	1,511,087
RTC	$0.37	72.09%	$10.86M	187,018,434

Symbol	Price	Change %	Market Cap	Volume
JEWL	$0.00	-90.83%	$2.78M	470,134
LXEH	$6.84	-70.25%	$26.82M	1,373,607
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644

Quick Links

MEIP $1.97 (+0.81%) Quote details